In nulliparous women, selective midline episiotomy may help reduce the risk of third-degree perineal lacerations, when compared to routine episiotomy, according to the results of a study published in the March issue of the American Journal of Obstetrics and Gynecology.
Alexander Rodriguez, MD, of the Antioquia University Medical School in Medellin, Colombia, and colleagues randomly assigned 446 nulliparous women with deliveries after at least 28 weeks' gestation to undergo either routine episiotomy or selective episiotomy, which was performed only in cases of forceps delivery, fetal distress, shoulder dystocia, or when the attending physician anticipated a severe laceration.
The researchers found that the rate of third- or fourth-degree perineal lacerations was significantly higher in patients who underwent routine episiotomy compared to those who underwent selective episiotomy (14.3 % vs. 6.8%). Further analysis showed that only the reduction in third-degree lacerations was significant. But they also found that periurethral, labia minora, and superficial vaginal lacerations were significantly more common in the selective episiotomy group.
"Our study is the first randomized clinical trial in the world comparing the routine use of midline episiotomy versus the use of selective midline episiotomy in nulliparous patients in the prevention of third- and fourth-degree lacerations," the authors conclude. "We recommend performing selective episiotomy in all birth centers when caring for nulliparous women."
Rodriguez A, Arenas EA, Osorio AL, et al. Selective vs routine midline episiotomy for the prevention of third- or fourth-degree lacerations in nulliparous women. Am J Obstet Gynecol. 2008;198:285.e1-.e4. doi:10.1016/j.ajog.2007.11.007.
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More